SCHEMBL9495886

SCHEMBL9495886

O=C(O)C(=O)OC1(c2ccc3c(c2)OCO3)CN2CCC1CC2

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
TSHR P16473 1/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
MAPK1 P28482 1/20 0.37
POLB P06746 1/20 0.37
HPGD P15428 1/20 0.36
HTR1D P28221 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C19 P33261 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
MCHR1 Q99705 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9492485 0.93 KDM4E (0.38) ALDH1A1TSHRMEN1KMT2AHPGD
Oxalic Acid SCHEMBL9495879 0.80 KMT2A (0.49) ALDH1A1MEN1KMT2ACHRM2CHRM5
SCHEMBL9492093 0.78 CHRM2 (0.39) MEN1KMT2ANPC1RAB9ACHRM2
SCHEMBL9494634 0.78 SLC6A2 (0.43) ALDH1A1TSHRMEN1KMT2ACHRM2
SCHEMBL9492980 0.75 KMT2A (0.55) KMT2ACHRM2CHRM5CHRM1CHRM3
SCHEMBL9495675 0.74 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL9493425 0.74 CHRM3 (0.45) KMT2ACHRM2CHRM5CHRM3
Oxalic Acid SCHEMBL9492479 0.72 KMT2A (0.49) ALDH1A1KMT2ANPC1RAB9ACHRM2
SCHEMBL14808682 0.72 ALDH1A1 (0.39) ALDH1A1MEN1KMT2APOLBHPGD
SCHEMBL9492217 0.70 SLC6A2 (0.37) KMT2APOLBCHRM2CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5177084-A 1-Azabicycles, Treating Mental Disorders MERCK SHARP & DOHME LTD. (GB) 1993-01-05 US disclosed
EP-0412797-A2 The therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes MERCK SHARP & DOHME LTD. (GB) 1991-02-13 EP disclosed